122 related articles for article (PubMed ID: 2600602)
1. Immunogenicity of a soluble partially purified oncofetal antigen from murine fibrosarcoma in syngeneic mice.
Barsoum AL; Coggin JH
J Biol Response Mod; 1989 Dec; 8(6):579-92. PubMed ID: 2600602
[TBL] [Abstract][Full Text] [Related]
2. Differential recognition of murine tumor-associated oncofetal transplantation antigen and individually specific tumor transplantation antigens by syngeneic cloned BALB/c and RFM mouse T cells.
Rohrer JW; Rohrer SD; Barsoum A; Coggin JH
J Immunol; 1994 Jan; 152(2):754-64. PubMed ID: 7904290
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization of 1-butanol-extracted murine tumor-specific transplantation antigens.
LeGrue SJ; Pellis NR; Riley LB; Kahan BD
Cancer Res; 1985 Jul; 45(7):3164-72. PubMed ID: 2408745
[TBL] [Abstract][Full Text] [Related]
4. Production, safety and antitumor efficacy of recombinant Oncofetal Antigen/immature laminin receptor protein.
Barsoum AL; Liu B; Rohrer JW; Coggin JH; Tucker JA; Pannell LK; Schwarzenberger PO
Biomaterials; 2009 Jun; 30(17):3091-9. PubMed ID: 19268360
[TBL] [Abstract][Full Text] [Related]
5. Characterization of tumor rejection antigen molecules of chemically induced murine colon tumor C-C26.
Sato N; Yagihashi A; Okubo M; Torigoe T; Takahashi S; Sato T; Kikuchi K
Cancer Res; 1987 Jun; 47(12):3147-51. PubMed ID: 3581064
[TBL] [Abstract][Full Text] [Related]
6. Delayed hypersensitivity to crude and partially purified murine tumor-specific transplantation antigens and alloantigens utilizing the footpad swelling assay.
Macek CM; Kahan BD; Pellis NR
J Immunol; 1980 Oct; 125(4):1639-43. PubMed ID: 6157743
[TBL] [Abstract][Full Text] [Related]
7. Analysis of murine oncofetal antigens as tumor-associated transplantation antigens.
Chism SE; Wallis S; Burton RC; Warner NL
J Immunol; 1976 Nov; 117(5 Pt.2):1870-7. PubMed ID: 993583
[TBL] [Abstract][Full Text] [Related]
8. Partial purification of C-C36 tumor rejection antigen molecules commonly expressed on syngeneic murine colon tumors, C-C36 and C-C26.
Sato N; Sato T; Takahashi S; Fujimoto N; Koshiba H; Ishii Y; Kikuchi K
Jpn J Cancer Res; 1986 May; 77(5):473-9. PubMed ID: 3089978
[TBL] [Abstract][Full Text] [Related]
9. 37 kiloDalton oncofetal antigen protein and immature laminin receptor protein are identical, universal T-cell inducing immunogens on primary rodent and human cancers.
Coggin JH; Barsoum AL; Rohrer JW
Anticancer Res; 1999; 19(6C):5535-42. PubMed ID: 10697612
[TBL] [Abstract][Full Text] [Related]
10. Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity.
Shu SY; Chou T; Sakai K
J Immunol; 1989 Jul; 143(2):740-8. PubMed ID: 2738408
[TBL] [Abstract][Full Text] [Related]
11. Subsets of oncofetal antigen-induced T-cells: ability to mediate antitumor immune response.
Gautam S; Deodhar SD
J Natl Cancer Inst; 1983 May; 70(5):923-30. PubMed ID: 6601736
[TBL] [Abstract][Full Text] [Related]
12. [Biochemical characterization of tumor rejection antigen (TRA) and genetic control in anti-TRA immune responses].
Fujiwara H; Suda T; Shimizu J; Muramatsu M; Kimura K; Hamaoka T
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):646-52. PubMed ID: 2468311
[TBL] [Abstract][Full Text] [Related]
13. Afferent and efferent specificity in the induction and elicitation of parental cross-protective immunity by an immunogenic murine tumor variant: associative recognition of a unique tumor-specific antigen on somatic cell hybrids.
LeGrue SJ; Ananthaswamy HN; Simcik WJ
Cancer Res; 1989 Sep; 49(17):4747-51. PubMed ID: 2474372
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
Roberts LK
J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
[TBL] [Abstract][Full Text] [Related]
15. Immunogenic variants of a murine fibrosarcoma induced by mutagenesis: requirement of viable cells for antigen-specific cross-protection.
LeGrue SJ; Simcik WJ; Frost P
Cancer Res; 1987 Aug; 47(16):4413-6. PubMed ID: 3607772
[TBL] [Abstract][Full Text] [Related]
16. Partial characterization of n-butanol-solubilized rejection-type antigens of syngeneic murine colon tumors.
Sato N; Kikuchi K
J Natl Cancer Inst; 1985 Apr; 74(4):883-8. PubMed ID: 3857382
[TBL] [Abstract][Full Text] [Related]
17. Protective immunity to progressive tumors can be induced by antigen presented on regressor tumors.
Flood PM; Schreiber H; Ron Y
J Immunol; 1987 May; 138(10):3573-9. PubMed ID: 3571978
[TBL] [Abstract][Full Text] [Related]
18. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
19. T-cell-mediated antitumor immune response induced by oncofetal antigens.
Gautam S; Deodhar SD
J Natl Cancer Inst; 1981 Oct; 67(4):939-45. PubMed ID: 6974275
[TBL] [Abstract][Full Text] [Related]
20. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
